RxDoctor Payments Data

Sara Ocheltree

Critical Care Medicine · Phoenix, AZNPI 1871937151

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.3% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $379 and has fallen 60.2% since, to $151 in 2024.

$1,029in general payments, 2019–2025

Across 48 payments — averaging $21.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$174
  • Genentech USA, Inc.$100
  • Alnylam Pharmaceuticals Inc.$82
  • Johnson & Johnson$79
  • Kestra Medical Technology Services, Inc.$66
  • AstraZeneca$55
  • plus $473 from 16 others

What the payments were for

  • Food & beverage$92990%
  • Education$10010%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,029 in reported general payments places this provider in the 65th percentile of 175 critical care medicine providers in Arizona.

See all critical care medicine providers in Arizona

Other critical care medicine in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →